India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>Paushak is undergoing a INR 240 crore capex program to expand its downstream capacities and move into semi-specialized products, impacting near-term profitability.</li>
<li>The company’s strong market position in phosgene derivatives and custom manufacturing for global players underpins its long-term growth potential despite current financial pressures.</li>
<li>While elevated valuations reflect short-term capex strain, Paushak’s long-term growth trajectory and strategic expansion reinforce its strong market outlook, maintaining a bullish stance for the future.</li>
</ul>


Paushak is undergoing a INR 240 crore capex program to expand its downstream capacities and move into semi-specialized products, impacting near-term profitability.
The company’s strong market position in phosgene derivatives and custom manufacturing for global players underpins its long-term growth potential despite current financial pressures.
While elevated valuations reflect short-term capex strain, Paushak’s long-term growth trajectory and strategic expansion reinforce its strong market outlook, maintaining a bullish stance for the future.


Business Breakdown: Paushak Ltd - Phosgene Chemistry Powering Long-Term Growth

India

Paushak Ltd. manufactures specialty chemicals.  The Company produces phosgene gas and phosgene based chemicals that are used in pesticides, pharmaceuticals, dyes, plastics, perfumes, and other products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Paushak Ltd (PAUS IN)

Business Breakdown: Paushak Ltd - Phosgene Chemistry Powering Long-Term Growth

Paushak invests INR 240 crore in capex for downstream expansion, impacting short-term profits but bolstering long-term growth potential and market...

Sudarshan Bhandari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Business Breakdown: Paushak Ltd - Phosgene Chemistry Powering Long-Term Growth

​Paushak invests INR 240 crore in capex for downstream expansion, impacting short-term profits but bolstering long-term growth potential and market...

Sudarshan Bhandari

Paushak invests INR 240 crore in capex for downstream expansion, impacting short-term profits but bolstering long-term growth potential and market...